Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

ESTRO 2022 DynamicARC® Symposium

20/07/2022
/ Webinar

El futuro de la Protonterapia

20/07/2022
/ Webinar

IBA está desarrollando el futuro de la Protonterapia

Junto con sus clientes y socios industriales, IBA está dando forma al futuro de la terapia de protones...

Proteus – Diseñado por usuarios y para usuarios

09/06/2022
/ Webinar

Diseñado para conseguir la excelencia clínica y el más avanzado tratamiento del paciente, Proteus® es un sistema de protonterapia basado en la versatilidad. A...

The State of Proton Therapy in the U.S.

14/09/2022
/ Webinar
/
Clinical Trial
Proton therapy center
Chemotherapy

During ISOP 2022, James Mets presented The State of Proton Therapy in the U.S. Watch the webinar above.

Role of Proton Therapy in Radiation Oncology

14/09/2022
/ Webinar
/
Proton therapy center

During ISOP 2022, Minesh Mehta presented the Role of Proton Therapy in Radiation Oncology. Watch the webinar above

Expanding Proton Therapy to Community Oncology Practices

14/09/2022
/ Webinar
/
Clinical Trial

During ISOP 2022, Barbara McAneny how to expand Proton Therapy to Community Oncology Practices. Watch the webinar above.

Introduction to IBA PT Dosimetry Solutions

14/09/2022
/ Webinar

During ISOP 2022, Anthony Nagle presented the Introduction to IBA PT Solutions. Watch the webinar above.

Keeping Systems Up to Date - Hyperplatinum

14/09/2022
/ Webinar
/
Proton therapy center

During ISOP 2022, Lei Dong presented how to Keep Systems Up to Date - Hyperplatinum. Watch the webinar above.

The Promise of ConformalFLASH Therapy

14/09/2022
/ Webinar

During ISOP 2022, Costas Koumenis presented The Promise of ConformalFLASH Therapy. Watch the webinar below.

A Journey to DynamicARC: recent breakthrough and future roadmap

14/09/2022
/ Webinar
/
PT101

During ISOP 2022, Xuanfeng Ding presented "A Journey to DynamicARC: recent breakthrough and future roadmap". Watch the webinar above.